Radar · Life Sciences Tech in United Kingdom
Best Life Sciences Tech Companies in United Kingdom
The 418 best Life Sciences Tech companies in United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Isomorphic Labs.
By Riya SenguptaFinancials
418companies tracked
$5.3Bdisclosed funding
0unicorns
171have raised
Life Sciences Tech companies in the United Kingdom don't lack for ambition, and this directory ranks 418 of them by disclosed equity funding and recent funding momentum. Total disclosed funding across the cohort sits at $5.3B, but that number tells only part of the story. Isomorphic Labs alone accounts for $2.7B of it, which means one company is carrying more than half the sector's entire disclosed capital. That's concentration worth knowing before you read anything else.
So what's driving the rest of the field? App-layer momentum is real: median install growth across life sciences and healthcare apps is running at roughly 43% year-over-year, which I'd argue signals genuine end-user pull, not just institutional enthusiasm. Automata ($107M), Relation ($65M), and Chemify ($43M) represent the next funding tier, each operating well below Isomorphic's scale but drawing backing from investors like Entrepreneur First, Cambridge Angels, and Oxford University Innovation. Regulatory compliance and intellectual property protection are shaping product priorities across the cohort, and you can see that pressure reflected in where the capital is actually going. The directory's a useful filter if you need to move fast on competitive intelligence.
Sources & further reading
- LifeSciencesIntelligence
- EVERSANA
FLIAR INTELLIGENCE · LIFE SCIENCES TECH × UNITED KINGDOM
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
89%cloud-native stacks
2025funding peak (by rounds)
8unicorns
2018median founding year
384kcombined LinkedIn audience
37%of audience held by top 3
7companies hiring publicly (12 mo)
Ranked: Best Life Sciences Tech companies in United Kingdom
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Isomorphic Labs Digital platform focused on revolutionizing drug discovery using AI 60Funding top 12%AI top 20%Innovation top 30%Patents top 33% All 11 signals ▾Fundingtop 12% AItop 20% Innovationtop 30% Patentstop 33% Moattop 39% Talentbottom 49% Growthbottom 47% Techbottom 46% Globalbottom 37% Marketbottom 36% Newsbottom 25% Funding: Raised $2.7B across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Classified as an AI company rank vs industry peers · Fliar Intelligence Index 60/100 | $2.7B | 1 mo ago | — | Demis Hassabis Founder & CEO | WebflowThree.jsGSAP+14 | Top 5M | 19 patents AI-driven drug discovery: protein‑ligand modeling, molecule property prediction, synthesis feasibility. | — |
| 2 | Exscientia Developer of artificial intelligence software for identifying potential drug candidates | $429M | 30 mo ago | — | Chris Gibson Co-Founder & CEO | — | — | 81 patents Patents concentrated in chemistry & materials | — |
| 3 | Genomics Provider of genomic risk assessment and prevention platform 64Patents top 19%Innovation top 24%Funding top 24%Talent top 28% All 9 signals ▾Patentstop 19% Innovationtop 24% Fundingtop 24% Talenttop 28% Moattop 32% Growthtop 45% Globaltop 46% Techtop 50% Marketbottom 40% Patents: 48 patents matched (strict assignee match) · 33 filings since 2022 vs 13 in 2017-21 Innovation: 48 patents (top 22% of patent-holders) · 33 filings since 2022 vs 13 in 2017-21 rank vs industry peers · Fliar Intelligence Index 64/100 | $161M | 29 mo ago | — | Rebecca H Founder & Principal | HubSpot CMS HubApple iCloud Mailcore-js+14 | Top 5M | 48 patents Software platforms for computational analysis of genomic sequencing data | — |
| 4 | Genomics Provider of a platform for the analysis of genomic sequence data 67Patents top 20%Moat top 21%Innovation top 24%Funding top 30% All 13 signals ▾Patentstop 20% Moattop 21% Innovationtop 24% Fundingtop 30% Partnerstop 32% Producttop 35% Talenttop 35% Markettop 41% Growthtop 49% Fin. healthbottom 46% Globalbottom 45% Techbottom 33% Newsbottom 21% Patents: 48 patents matched (strict assignee match) · 33 filings since 2022 vs 13 in 2017-21 Moat: Editorial + unicorn rating 8/10 · IP moat: 48 patents rank vs industry peers · Fliar Intelligence Index 67/100 | $146M | 29 mo ago | 76 76 → 184 (+142%) | Peter Donnelly Co-Founder & CEO | — | — | 48 patents Bioinformatics software platforms for computational analysis of genomic sequencing data | 2 awards |
| 5 | Healx Provider of AI-powered drug discovery solutions for rare diseases 64Innovation top 25%AI top 26%Moat top 26%Patents top 27% All 12 signals ▾Innovationtop 25% AItop 26% Moattop 26% Patentstop 27% Fundingtop 29% Talenttop 38% Growthtop 42% Techtop 48% Globalbottom 47% Marketbottom 46% Fin. healthbottom 28% Newsbottom 18% Innovation: 105 patents (top 10% of patent-holders) · 57 filings since 2022 vs 48 in 2017-21 AI: Classified as an AI company · Product described with: ai-powered, machine learning rank vs industry peers · Fliar Intelligence Index 64/100 | $115M | 22 mo ago | 80 80 → 69 (-14%) | David Brown Co-Founder | WordPressMySQLPHP+22 | Top 10M | 105 patents Drug repurposing of existing compounds for rare cancers and polycystic kidney disease | — |
| 6 | Automata Developer of modular lab automation platforms for biological research workflows 64Funding top 25%Product top 25%Tech top 27%Moat top 31% All 11 signals ▾Fundingtop 25% Producttop 25% Techtop 27% Moattop 31% Innovationtop 32% Fin. healthtop 33% Newstop 43% Growthtop 48% Talentbottom 49% Marketbottom 44% Globalbottom 39% Funding: Raised $107M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) Product: 7 distinct product lines · Company stage: Series C rank vs industry peers · Fliar Intelligence Index 64/100 | $107M | 4 mo ago | 40 | Mostafa ElSayed Co-Founder & CEO | WordPress Block EditorWordPressApple iCloud Mail+33 | Top 5M | — | 1 partnership |
| 7 | Causaly Provider of an AI platform for life sciences and biomedical research | $93M | 35 mo ago | 37 | Yiannis Kiachopoulos Co-Founder & CEO | WebflowApple iCloud MailGoogle Workspace+22 | Top 5M | — | — |
| 8 | Basecamp Research Biotechnology company using AI to explore undiscovered biology for applications in pharma, food, and industry 48AI top 20%Funding top 25%Talent top 38%Moat bottom 48% All 10 signals ▾AItop 20% Fundingtop 25% Talenttop 38% Moatbottom 48% Growthbottom 47% Techbottom 47% Partnersbottom 43% Newsbottom 41% Globalbottom 39% Marketbottom 27% AI: Classified as an AI company Funding: Raised $85.0M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 48/100 | $85M | 21 mo ago | 10 | Oliver Vince Co-Founder | WordPressApple iCloud MailMySQL+21 | Top 10M | — | 1 launch |
| 9 | LabGenius Manufacturer of synthetic DNA libraries | $73M | 24 mo ago | 54 | James Field CEO & Founder | — | — | 12 patents Protein engineering platforms and synthetic DNA assembly technologies for biotech development | — |
| 10 | LabGenius Therapeutics Developer of an automated platform for therapeutic antibody discovery | $70M | 24 mo ago | — | James Field Founder & CEO | WordPressMySQLMariaDB+20 | Top 10M | — | 1 job opening · 1 partnership |
| 11 | Relation AI-based drug development tools for researchers 55Funding top 25%Talent top 28%AI top 30%Growth top 35% All 8 signals ▾Fundingtop 25% Talenttop 28% AItop 30% Growthtop 35% Moattop 36% Techbottom 43% Globalbottom 37% Marketbottom 27% Funding: Raised $65.3M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $65M | 6 mo ago | 12 | Jake Taylor-King Co-Founder & Chief Innovation Officer | Craft CMSApple iCloud MailGoogle Workspace+11 | Top 10M | — | 1 partnership · 1 award |
| 12 | Latentlabs Developer of generative AI models for programmable biology 60Funding top 25%AI top 30%Growth top 35%Moat top 40% All 8 signals ▾Fundingtop 25% AItop 30% Growthtop 35% Moattop 40% Talentbottom 49% Globalbottom 48% Techbottom 43% Marketbottom 40% Funding: Raised $50.0M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Classified as an AI company · Product described with: generative ai rank vs industry peers · Fliar Intelligence Index 60/100 | $50M | 16 mo ago | — | Simon Kohl Founder & CEO | WordPressMySQLPHP+18 | Top 5M | — | — |
| 13 | C4X Discovery Developer of optimized drug discovery and design services | $43M | 29 mo ago | 46 | — | WordPressMySQLPHP+15 | Top 50M | 130 patents Small‑molecule inhibitors of MALT1, NRF2 agonists, and integrin blockers for immuno‑inflammatory therapy | — |
| 14 | Chemify Developer of a platform for digitizing chemistry and chemical discovery 64Growth top 20%Funding top 26%AI top 30%Tech top 40% All 11 signals ▾Growthtop 20% Fundingtop 26% AItop 30% Techtop 40% Talentbottom 49% Marketbottom 44% Globalbottom 42% Moatbottom 42% Patentsbottom 40% Innovationbottom 39% Newsbottom 17% Growth: Web rank 50,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo Funding: Raised $43.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $43M | 4 mo ago | 40 | Lee Cronin Founder & CEO | Node.jsUbuntuTailwind CSS+9 | Top 5M | 2 patents Modular catalytic reactors and networked chemical processing platforms for scalable synthesis | — |
| 15 | Laverock Therapeutics Developer of next generation of programmable cell therapies 24Funding top 29%Moat top 42%Talent bottom 49%Global bottom 45% All 6 signals ▾Fundingtop 29% Moattop 42% Talentbottom 49% Globalbottom 45% Techbottom 43% Marketbottom 27% Funding: Raised $39.3M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) Moat: Editorial + unicorn rating 4/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 24/100 | $39M | 11 mo ago | 6 | David Venables CEO | WebflowGSAPcore-js+13 | Top 50M | — | — |
| 16 | Eagle Genomics Developer of cloud-based software solutions for genomic analysis | $39M | 32 mo ago | 125 | Anthony Finbow CEO | HubSpot CMS HubApple iCloud MailMicrosoft 365+17 | Top 50M | — | — |
| 17 | Cirdan Imaging Laboratory Information System for clinical laboratories 53Product top 30%Growth top 31%Moat top 37%Talent top 38% All 12 signals ▾Producttop 30% Growthtop 31% Moattop 37% Talenttop 38% Fundingtop 39% Fin. healthtop 45% Techbottom 47% Marketbottom 46% Globalbottom 45% Innovationbottom 44% Patentsbottom 33% Newsbottom 20% Product: 4 distinct product lines · Company stage: Series B Growth: Revenue +39% YoY · Web rank 50,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 53/100 | $24M | 2 mo ago | 84 | Cahal Cormican Co-Founder | WordPressMySQLPHP+18 | Top 10M | 6 patents Patents concentrated in health & consumer products | — |
| 18 | Eleven AI-based RNA drug development platform for researchers 55Growth top 28%Talent top 28%Funding top 31%AI top 45% All 8 signals ▾Growthtop 28% Talenttop 28% Fundingtop 31% AItop 45% Newsbottom 48% Techbottom 44% Globalbottom 37% Marketbottom 25% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $22M | 14 mo ago | 12 12 → 28 (+133%) | Shaul Ilan Co-Founder | WordPressMySQLPHP+17 | Top 10M | — | 1 launch |
| 19 | Econic Biosciences Developer of a platform for the discovery and development of targeted therapies for cancer | $20M | 25 mo ago | 10 | Richard Koche Co-Founder | — | — | — | — |
| 20 | Techspert Leading expert network for healthcare and life sciences 60Funding top 29%Tech top 30%Growth top 32%Moat top 39% All 7 signals ▾Fundingtop 29% Techtop 30% Growthtop 32% Moattop 39% Talentbottom 49% Globalbottom 46% Marketbottom 42% Funding: Raised $18.1M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Tech: 43 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 rank vs industry peers · Fliar Intelligence Index 60/100 | $18M | 3 mo ago | 53 53 → 71 (+34%) | David Holden Co-Founder & CEO | HubSpot CMS HubSalesforceBootstrap+25 | Top 10M | — | — |
| 21 | Cumulus Neuro AI and cloud-based brain physiology analysis tool for clinical trials 62Growth top 20%Funding top 30%News top 33%Moat top 39% All 7 signals ▾Growthtop 20% Fundingtop 30% Newstop 33% Moattop 39% Talentbottom 49% Marketbottom 47% Globalbottom 39% Growth: Headcount 21 → 41 (+95%) across vintages · Fresh capital in last 24 mo Funding: Raised $15.2M across 7 rounds · 7 rounds over 9 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 62/100 | $15M | 11 mo ago | 41 41 → 35 (-15%) | Brian Murphy Co-Founder & Chief Scientific Officer | — | — | — | — |
| 22 | Electric Twin AI-powered digital twin technology for research and clinical applications in the life sciences industry 60Growth top 15%News top 22%Funding top 33%Talent top 38% All 8 signals ▾Growthtop 15% Newstop 22% Fundingtop 33% Talenttop 38% AItop 45% Techtop 46% Globalbottom 32% Marketbottom 25% Growth: Fresh capital in last 24 mo News: 6 BI events in 12 mo (of 6 tracked, 1 types) · 6 high-value events (IPO/M&A/funding/contracts) in 12 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $14M | 9 mo ago | — | Alex Cooper Co-Founder & CEO | Framer SitesYouTubeReact+21 | Top 50M | — | 2 awards |
| 23 | IgniteData Provider of solutions for transforming patient data for clinical trials through archer technology 22News top 28%Funding top 39%Moat top 39%Talent top 41% All 6 signals ▾Newstop 28% Fundingtop 39% Moattop 39% Talenttop 41% Globalbottom 37% Marketbottom 28% News: 4 BI events in 12 mo (of 4 tracked, 2 types) · Top themes: Funding, Leadership Funding: Raised $12.7M across 6 rounds · 6 rounds over 9 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 22/100 | $13M | 7 mo ago | 11 | Dan Hydes Founder | — | — | — | — |
| 24 | Oxford Drug Design Provider of computer-aided design of antibiotics for MDR infections 32Talent top 28%Funding top 30%Moat top 32%Patents top 38% All 9 signals ▾Talenttop 28% Fundingtop 30% Moattop 32% Patentstop 38% Innovationtop 40% Producttop 41% Globalbottom 40% Marketbottom 26% Techbottom 23% Talent: Analyst team rating 4/5 · 3 named leaders on record Funding: Raised $12.4M across 7 rounds · 7 rounds over 9 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 32/100 | $12M | 4 mo ago | 9 | Graham Richards Founder & Chairman | — | — | 46 patents Antibacterial aminoacyl‑tRNA synthetase inhibitors based on sulfonamide/aryl‑sulfinyl scaffolds | — |
| 25 | Scripta Therapeutics Developer of therapeutics modulating transcription factor activity for disease treatment 27Funding top 36%Talent top 38%Tech bottom 49%Global bottom 45% All 5 signals ▾Fundingtop 36% Talenttop 38% Techbottom 49% Globalbottom 45% Marketbottom 25% Funding: Raised $11.9M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 27/100 | $12M | 7 mo ago | — | Jerry Huang Co-Founder & VP Machine Learning | Framer SitesApple iCloud MailReact+13 | Top 50M | — | — |
| 26 | CardiaTec Provider of novel therapeutic discovery platform for cardiovascular diseases | $11M | 21 mo ago | 5 | Thelma Zablocki Co-Founder & COO | — | — | — | 1 award |
| 27 | Antiverse Developer of computational platform for de novo design of antibody therapeutics 48AI top 30%Tech top 32%Talent top 34%Funding top 39% All 8 signals ▾AItop 30% Techtop 32% Talenttop 34% Fundingtop 39% Moattop 48% Newsbottom 41% Globalbottom 39% Marketbottom 22% AI: Classified as an AI company · Product described with: machine learning Tech: 35 technologies across 5/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 48/100 | $10M | 3 mo ago | 7 | Murat Tunaboylu Co-Founder & CEO | WebflowApple iCloud MailGoogle Workspace+19 | Top 50M | — | — |
| 28 | Omnigen Biodata Moon - Experienced digital folks who craft interactive products and experiences | $9M | 16 mo ago | 15 | Manjinder Sandhu Founder & CEO | — | — | — | — |
| 29 | Rgrid Online platform for real-time research process automation and data management | $8M | 19 mo ago | 10 | Amber Hill Founder & CEO | TypeScriptZone.jsAngular+9 | Top 50M | — | — |
| 30 | Ignota Labs AI-driven toxicity prediction tools for early-stage drug discovery scientists | $7M | 15 mo ago | 9 | Layla Hosseini-Gerami Co-Founder | — | — | — | 2 partnerships · 1 award |
| 31 | DaltonTx Developer of AI-enabled platforms for drug discovery and development 35Talent top 28%Funding top 40%AI top 45%Global bottom 48% All 6 signals ▾Talenttop 28% Fundingtop 40% AItop 45% Globalbottom 48% Techbottom 36% Marketbottom 25% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated Funding: Raised $5.4M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $5M | 8 mo ago | — | Adrian Rossall Co-Founder & CTO | Framer SitesReactLenis+7 | Top 50M | — | — |
| 32 | Little Journey Provider of digital health solutions for pediatric healthcare 29Growth top 35%Funding top 36%Talent top 38%Product top 47% All 8 signals ▾Growthtop 35% Fundingtop 36% Talenttop 38% Producttop 47% Globalbottom 39% Techbottom 34% Marketbottom 19% Newsbottom 18% Growth: Fresh capital in last 24 mo Funding: Raised $5.2M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 29/100 | $5M | 11 mo ago | 1 | Chris Evans Co-Founder & CEO | HubSpot CMS HubApple iCloud MailMicrosoft 365+9 | Top 10M | — | 1 job opening · 1 award |
| 33 | TernaryTx Developer of computational platform for molecular glue discovery and design 24Talent top 38%Funding top 42%AI top 45%Global bottom 48% All 6 signals ▾Talenttop 38% Fundingtop 42% AItop 45% Globalbottom 48% Marketbottom 25% Techbottom 22% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $4.8M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $5M | 3 mo ago | — | Chris Tame Co-Founder & CEO | Tiiny HostAmazon Web ServicesPlausible+4 | Top 50M | — | 1 internship |
| 34 | Entelo Bio Developer of single-cell isoform sequencing platform for disease research 42Talent top 38%Funding top 47%Global bottom 48% All 3 signals ▾Talenttop 38% Fundingtop 47% Globalbottom 48% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $4.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $4M | 1 mo ago | — | Adam Cribbs Co-Founder & CTO | — | — | — | 1 launch · 1 partnership · 1 award |
| 35 | Caeruleus Genomics A computational biotech company focused on functional cell profiling and target discovery | $4M | 18 mo ago | — | Adam Cribbs Co-Founder & CTO | — | — | — | — |
| 36 | HotHouse Therapeutics Developer of plant-based therapeutics using AI-driven biosynthetic pathways 60Talent top 28%AI top 45%Funding top 50%Global bottom 33% All 4 signals ▾Talenttop 28% AItop 45% Fundingtop 50% Globalbottom 33% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-driven rank vs industry peers · Fliar Intelligence Index 60/100 | $4M | 6 mo ago | — | David Sheppard Co-Founder & CEO | — | — | — | 1 award |
| 37 | Concinnity Provider of AI-driven platform for developing gene and cell therapies | $4M | 18 mo ago | — | Jessica Birt Co-Founder & CEO | — | — | — | — |
| 38 | Sonrai Analytics Developer of software for data analytics and ingishts | $4M | 9 mo ago | 16 16 → 31 (+94%) | Darragh Mcart Co-Founder & CEO | WordPressMySQLPHP+27 | Top 50M | — | — |
| 39 | Coding Bio AI-assisted platform for cell therapy development 19AI top 45%Talent top 45%Funding top 49%Global bottom 36% All 5 signals ▾AItop 45% Talenttop 45% Fundingtop 49% Globalbottom 36% Marketbottom 19% AI: Product described with: machine learning Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 19/100 | $3M | 5 mo ago | 5 | Yulia Lampi Co-Founder | — | — | — | — |
| 40 | Gibran Platform offering AI research and development solutions 45AI top 20%Talent top 28%Growth top 35%Funding bottom 48% All 7 signals ▾AItop 20% Talenttop 28% Growthtop 35% Fundingbottom 48% Globalbottom 45% Techbottom 29% Marketbottom 25% AI: Classified as an AI company Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 45/100 | $3M | 9 mo ago | — | Govind Balakrishnan Co-Founder | Google Font APIGoDaddyCloudflare Bot Management+2 | Top 50M | — | — |
| 41 | huumun Developer of digital marketing automation platform | $2M | 18 mo ago | 36 36 → 68 (+89%) | — | — | — | — | — |
| 42 | Neuranics Developer of magnetic sensing technology for next-generation wearable systems 21Talent top 38%Growth top 45%Moat top 47%Funding bottom 47% All 10 signals ▾Talenttop 38% Growthtop 45% Moattop 47% Fundingbottom 47% Patentsbottom 41% Globalbottom 40% Innovationbottom 31% Techbottom 31% Marketbottom 27% Newsbottom 21% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 21/100 | $2M | 14 mo ago | 10 | Hadi Heidari Co-Founder & CTO | WordPressMySQLPHP+17 | Top 10M | 2 patents Continuous cardiac arrhythmia monitoring using wearable sensor technology | 1 launch · 1 partnership |
| 43 | Sable Bio AI-powered platform for drug safety prediction within the pharmaceutical industry 32Talent top 38%Funding top 44%AI top 45%Moat top 48% All 7 signals ▾Talenttop 38% Fundingtop 44% AItop 45% Moattop 48% Techbottom 45% Globalbottom 32% Marketbottom 28% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $1.9M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 32/100 | $2M | 9 mo ago | — | Josh Almond-Thynne Co-Founder | Framer SitesReactAmazon Web Services+10 | Top 50M | — | 1 partnership |
| 44 | PolyModels Hub Provider of a platform to accelerate drug development 29Talent top 28%News top 32%Funding top 43%Moat top 48% All 7 signals ▾Talenttop 28% Newstop 32% Fundingtop 43% Moattop 48% Techbottom 48% Globalbottom 37% Marketbottom 28% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated News: 3 BI events in 12 mo (of 4 tracked, 2 types) · +200% YoY rank vs industry peers · Fliar Intelligence Index 29/100 | $1M | 6 mo ago | — | Antonio Yankey Co-Founder | ContentfulApple iCloud MailGoogle Workspace+14 | Top 50M | — | 1 launch |
| 45 | New Wave Biotech Provider of AI downstream process optimization software for biotech industry | $1M | 17 mo ago | — | Oli Hall Co-Founder | — | — | — | — |
| 46 | Envoke Provider of an engagement platform for virtual instruments 35Growth top 35%Tech top 44%Funding top 50%Talent bottom 49% All 7 signals ▾Growthtop 35% Techtop 44% Fundingtop 50% Talentbottom 49% Productbottom 45% Globalbottom 37% Marketbottom 25% Growth: Fresh capital in last 24 mo Tech: 30 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 35/100 | $1M | 1 mo ago | — | Stuart Warrington Founder & CEO | BreakdanceWordPressMySQL+25 | Top 50M | — | — |
| 47 | Klaris Provider of AI-powered compliance solutions for medical device manufacturers 27Talent top 38%AI top 45%Funding bottom 47%Global bottom 45% All 6 signals ▾Talenttop 38% AItop 45% Fundingbottom 47% Globalbottom 45% Techbottom 39% Marketbottom 25% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated AI: Product described with: ai-powered rank vs industry peers · Fliar Intelligence Index 27/100 | $1M | 3 mo ago | — | Mihai Sorin Co-Founder & CTO | Apple iCloud MailGoogle WorkspaceGoogle Cloud+7 | Top 50M | — | — |
| 48 | Lab Thread Developer of a software platform for streamlining laboratory research and data | $1M | 11 mo ago | — | Deyan Sultov Co-Founder & CTO | — | — | — | 2 launchs |
| 49 | Giles Developer of an AI agent for medical and healthcare research | $946K | 12 mo ago | — | Constantin Gorgan Co-Founder | WordPressMySQLPHP+28 | Top 10M | — | 1 launch |
| 50 | Spotlight Pathology Developer of AI-powered decision support tools for blood cancer diagnosis 37AI top 35%Talent top 38%Funding bottom 47%Growth bottom 42% All 7 signals ▾AItop 35% Talenttop 38% Fundingbottom 47% Growthbottom 42% Marketbottom 37% Globalbottom 29% Newsbottom 21% AI: Product described with: ai-powered, machine learning Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 37/100 | $162K | 3 mo ago | — | Richard Byers Co-Founder | — | — | — | — |
Top 12 Life Sciences Tech companies in United Kingdom
#1
Series B · London, England · founded 2021$2.7Braised▾
Series B · London, England · founded 2021
Digital platform focused on revolutionizing drug discovery using AI. The company's computational tools analyze complex biological phenomena to assist in the design of molecules. The technology predicts how potential therapeutic compounds perform to facilitate the development of treatments for various diseases.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 12%AI
top 20%Innovation
top 30%Patents
top 33%Moat
top 39%Talent
bottom 49%Funding: Raised $2.7B across 2 rounds · 2 rounds over 1 yrs (2.0/yr) · Last round Series B (May 2026)
AI: Classified as an AI company
Innovation: 19 patents (top 47% of patent-holders) · 19 filings since 2022 vs 0 in 2017-21 · Deep-tech classification: Artificial Intelligence
Audience (LinkedIn): 95k LinkedIn followers — 24.7% of this cohort's audience
Funding rounds
- May 2026Series B$2.1B
- Mar 2025Series A$600M
Founders & team
Investors
Thrive Capital, Google Ventures, Alphabet, MGX, Temasek, CapitalG
Tech stack
<Model-Viewer>CloudflareCookiebotGoogle AnalyticsGoogle Hosted LibrariesGsap
#2
Series C · London, England · founded 2015 · 40 employees$106.5Mraised▾
Series C · London, England · founded 2015 · 40 employees
Developer of modular lab automation platforms for biological research workflows. This system integrates hardware and software to orchestrate laboratory processes, including sample handling and instrument management. The platform utilizes node-based design tools and software development kits to enable workflow configuration and simulation. It supports connectivity with external data systems and analytical models to facilitate automated execution of experimental protocols. The hardware components are configurable to accommodate various instruments and laboratory layouts, allowing for the management of multiple concurrent tasks.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 25%Product
top 25%Tech
top 27%Moat
top 31%Innovation
top 32%Fin. health
top 33%Funding: Raised $107M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) · Last round Series C (Jan 2026)
Product: 7 distinct product lines · Company stage: Series C
Tech: 55 technologies across 6/8 capability areas · Cloud: Amazon S3, Amazon Web Services · Devops: Varnish
Audience (LinkedIn): 19k LinkedIn followers — 4.9% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. Automata) announced in 12 mo
Funding rounds
- Jan 2026Series C$45M
- Oct 2023Series B$40M
- Feb 2022Series B$50M
- Mar 2019Series A$7.4M
Founders & team
Investors
Dimension, Octopus Ventures, Hummingbird Ventures, Isomer Capital, Possible Ventures, Aldea Ventures
Tech stack
Amazon Web ServicesApple Icloud MailClickceaseCloudflareCloudflare Bot ManagementCookiebot
#3
Series B · Lisburn, Northern Ireland · founded 2010 · 84 employees$23.6Mraised▾
Series B · Lisburn, Northern Ireland · founded 2010 · 84 employees
Cirdan Imaging designs manufactures and supplies medical imaging & informatics technology for the medical diagnosis and treatment of cancer. The company offers VividPath, a PACS image acquisition and viewer workstation to acquire, view, annotate, report, and store images in a database. Also provides gross specimen macro imaging systems for pathology laboratories; digital microscope cameras to support live onscreen review and image capture of slides; and medical imaging software solutions. The company has additional offices in Canada and Australia and offers products through a network of distributors in Europe, the Middle East, and Africa.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
Product
top 30%Growth
top 31%Moat
top 37%Talent
top 38%Funding
top 39%Fin. health
top 45%Product: 4 distinct product lines · Company stage: Series B
Growth: Revenue +39% YoY · Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Moat: Editorial + unicorn rating 7/10 · IP moat: 6 patents · 10 curated direct competitors tracked
Funding rounds
- Apr 2026Series B$4M
- Apr 2026Venture Debt$5.4M
- Oct 2024Series B$9.8M
- Oct 2023Series A$2.8M
Founders & team
Investors
Invest Northern Ireland, Qubis, Kernel Capital, Kainos Capital, EDS Ireland, British Business Bank
Tech stack
CloudflareCloudflare Bot ManagementCookieyesCore-JsElementorGoogle Analytics
#4
Series B · Glasgow, Scotland · founded 2020 · 40 employees$43Mraised▾
Series B · Glasgow, Scotland · founded 2020 · 40 employees
Developer of a platform for digitizing chemistry and chemical discovery. The platform combines chemistry, robotics, computation, machine learning, and a programming language to automate molecule creation. It aims to accelerate molecular discovery and bridge the gap between design and synthesis. The company focuses on developing novel compounds and materials.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Growth
top 20%Funding
top 26%AI
top 30%Tech
top 40%Talent
bottom 49%Market
bottom 44%Growth: Web rank 50,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo
Funding: Raised $43.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Feb 2026)
AI: Classified as an AI company · Product described with: machine learning
Audience (LinkedIn): 8k LinkedIn followers
Funding rounds
- Feb 2026Series B—
- Dec 2025Grant (prize money)$1.6M
- Oct 2025Series B$50M
- Oct 2024Grant (prize money)—
Founders & team
Investors
Gates, Triatomic, Horizons Ventures, Rocketship, Possible Ventures, Alix Ventures
Tech stack
Apple Icloud MailCloudflareCookiebotHstsHttp/3Jquery
#5
Seed · London, England · founded 2019 · 12 employees$65.3Mraised▾
Seed · London, England · founded 2019 · 12 employees
AI-based drug development tools for researchers. The company has developed software for target and drug discovery. The platform leverages human genetics, single-cell omics, and perturbational data for genetic disease management.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 25%Talent
top 28%AI
top 30%Growth
top 35%Moat
top 36%Tech
bottom 43%Funding: Raised $65.3M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) · Last round Seed (Nov 2025)
Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
AI: Classified as an AI company · Product described with: ai-based
Audience (LinkedIn): 16k LinkedIn followers — 4.2% of this cohort's audience
Activity (LinkedIn): 1 partnerships · 1 awards (incl. Novatis) announced in 12 mo
Funding rounds
- Nov 2025Seed$36.2M
- Nov 2024Seed$15M
- Jan 2024Seed$40.3M
- May 2022Seed$16M
Founders & team
Investors
DCVC, Magnetic Ventures, OMERS, Khosla Ventures, Firstminute Capital, ARK Investment Management
Tech stack
Apple Icloud MailCloudflareCraft CmsGoogle WorkspaceGsapHsts
#6
Acquired · London, England · founded 2016 · 53 employees$18.1Mraised▾
Acquired · London, England · founded 2016 · 53 employees
Leading expert network for healthcare and life sciences. Platform connecting healthcare and life science organizations with subject matter experts. It facilitates primary research by providing access to a network of professionals. The platform offers tools for expert identification, interview scheduling, and automated call analysis. It also provides features for data capture, transcript access, and quote sharing.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 29%Tech
top 30%Growth
top 32%Moat
top 39%Talent
bottom 49%Global
bottom 46%Funding: Raised $18.1M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) · Last round PE (Feb 2026)
Tech: 43 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 · Observability: Sentry
Growth: Headcount 39 → 53 (+36%) across vintages · Fresh capital in last 24 mo
Audience (LinkedIn): 7k LinkedIn followers
Funding rounds
- Feb 2026PE$6.7M
- Oct 2021Series B$12M
- Feb 2020Unattributed$4.9M
- Dec 2018Unattributed$1.3M
Founders & team
Investors
ACF Investors, BGF, Nauta Capital, Cambridge Angels, Palatine Private Equity, Martlet Capital
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesBootstrapCdnjsCloudflare
#7
Series A · Cardiff, Wales · founded 2017 · 7 employees$10.1Mraised▾
Series A · Cardiff, Wales · founded 2017 · 7 employees
Developer of computational platform for de novo design of antibody therapeutics. The platform combines machine learning techniques and cell line engineering for challenging targets. It facilitates design for drug targets, including G-protein coupled receptors and ion channels. The technology enables movement from target identification to functional antibody.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
AI
top 30%Tech
top 32%Talent
top 34%Funding
top 39%Moat
top 48%News
bottom 41%AI: Classified as an AI company · Product described with: machine learning
Tech: 35 technologies across 5/8 capability areas · Cloud: Cloudflare · Devops: Varnish
Talent: Analyst team rating 4/5 · 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 6k LinkedIn followers
Hiring (LinkedIn): 2 hiring posts in 12 mo (public) · momentum -2 · hiring: VP of Business Development and Licensing, VP of Antibody Development
Funding rounds
- Mar 2026Series A$9.3M
- Oct 2024Seed$4.6M
- Mar 2023Seed$3M
- Mar 2021Seed$1.9M
Founders & team
Investors
Development Bank of Wales, ACF Investors, Tensor Ventures, Wren Capital, Syndicate Room, UK Innovation Science & Seed Fund
Tech stack
Animate.CssApple Icloud MailCloudflareCloudflare Bot ManagementCore-JsFont Awesome
#8
Series A · Oxford, England · founded 2001 · 9 employees$12.4Mraised▾
Series A · Oxford, England · founded 2001 · 9 employees
Oxford Drug Design is a spinoff from the laboratory of Dr. Graham Richards at the University of Oxford and is focusing on developing novel antibiotics for multi-drug resistance bacterial infections. The company has developed a fast virtual screening and ligand analog searching platform to speed up the drug discovery process. Called 3D ElectroShape technology, the approach involves the use of their proprietary compound databases (containing over 23 million unique molecules), and a combination of structure- and ligand-based virtual screening to find ligands for target proteins.
Fliar Intelligence Index™ 32how this company ranks against its industry peers
Talent
top 28%Funding
top 30%Moat
top 32%Patents
top 38%Innovation
top 40%Product
top 41%Talent: Analyst team rating 4/5 · 3 named leaders on record · 3 C-suite/founder profiles curated
Funding: Raised $12.4M across 7 rounds · 7 rounds over 9 yrs (0.8/yr) · Last round Series A (Feb 2026)
Moat: Editorial + unicorn rating 7/10 · IP moat: 46 patents · 9 curated direct competitors tracked
Audience (LinkedIn): 3k LinkedIn followers
Funding rounds
- Feb 2026Series A$981.8K
- May 2022Series A$2.7M
- Nov 2019Series A$2.8M
- Nov 2019Grant (prize money)—
Founders & team
Investors
Europa, CARB-X, IP Group, o2h ventures, Busolantix Investment, ACF Investors
Tech stack
WordpressMysqlPhpGoogle MapsTwenty NineteenApache Http Server
#9
Series A · London, England · founded 2023$4Mraised▾
Series A · London, England · founded 2023
Developer of single-cell isoform sequencing platform for disease research. This platform reveals hidden biological information to facilitate the development of transformative therapies for chronic diseases. The technology offers unmatched resolution in decoding disease complexity, leading to a deeper understanding of disease mechanisms and potential treatment strategies. The platform is designed to provide researchers with detailed insights into cellular heterogeneity and gene expression patterns.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Talent
top 38%Funding
top 47%Global
bottom 48%Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $4.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series A (Apr 2026)
Global: Investors from 1 country beyond United Kingdom
Audience (LinkedIn): 2k LinkedIn followers
Activity (LinkedIn): 1 product launches · 1 partnerships · 1 awards (incl. Atrogi) announced in 12 mo
Funding rounds
- Apr 2026Series A$4M
Founders & team
Investors
Ananda Impact Ventures, Creator Fund
#10
Series A · Maidenhead, England · founded 2013 · 11 employees$12.7Mraised▾
Series A · Maidenhead, England · founded 2013 · 11 employees
Provider of solutions for transforming patient data for clinical trials through archer technology. It transforms the future of clinical trials through its cloud based virtual research assistant. It provides a system agnostic solution that automates the transfer of clinical data from electronic health records to electronic data capture systems, enhancing data quality and productivity. It also offers tool for researchers and healthcare organizations.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
News
top 28%Funding
top 39%Moat
top 39%Talent
top 41%Global
bottom 37%Market
bottom 28%News: 4 BI events in 12 mo (of 4 tracked, 2 types) · Top themes: Funding, Leadership
Funding: Raised $12.7M across 6 rounds · 6 rounds over 9 yrs (0.7/yr) · Last round Series A (Nov 2025)
Moat: Editorial + unicorn rating 7/10 · 9 curated direct competitors tracked
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
- Nov 2025Series A—
- Oct 2025Series A$1.7M
- Aug 2025Series A$8.1M
- May 2024Seed$8M
Founders & team
Investors
The FSE Group, Ukri, SpringTide, Oncology Ventures, FCA Venture Partners, Epsilon Health Investors
#11
Seed · London, England · founded 2024$4.8Mraised▾
Seed · London, England · founded 2024
Developer of computational platform for molecular glue discovery and design. The platform identifies protein surface hotspots for ternary complex formation using proprietary models. It prioritizes virtual effector proteins, enabling mechanism deconvolution. The technology facilitates computational discovery of targetable binding sites using simulations. It also offers a glue-specific virtual screening platform using artificial intelligence methods.
Fliar Intelligence Index™ 24how this company ranks against its industry peers
Talent
top 38%Funding
top 42%AI
top 45%Global
bottom 48%Market
bottom 25%Tech
bottom 22%Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $4.8M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Seed (Mar 2026)
AI: Product described with: artificial intelligence
Audience (LinkedIn): 3k LinkedIn followers
Funding rounds
- Mar 2026Seed$4.8M
- Feb 2025Seed—
Founders & team
Investors
Pace Ventures, i&i Bio, Daphni, Future Planet Capital
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesGoogle Font ApiOpen GraphPlausible
#12
Seed · Leeds, England · founded 2019$1.3Mraised▾
Seed · Leeds, England · founded 2019
Provider of an engagement platform for virtual instruments. The company offers a virtual demo platform intended for life science companies for remote demo purposes, including sales, training, and customer support.
Fliar Intelligence Index™ 35how this company ranks against its industry peers
Growth
top 35%Tech
top 44%Funding
top 50%Talent
bottom 49%Product
bottom 45%Global
bottom 37%Growth: Fresh capital in last 24 mo
Tech: 30 technologies across 4/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Recaptcha
Funding: Raised $1.3M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Seed (May 2026)
Audience (LinkedIn): 954 LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- May 2026Seed$2.2M
- May 2025Seed$1.3M
- Aug 2023Seed$1.3M
Founders & team
Investors
Mercia, Finance Yorkshire, Foresight Group
Tech stack
<Model-Viewer>Apache Http ServerBreakdanceCloudflareCloudflare Bot ManagementCookieyes
Funding & investor landscape
$5.3Btotal disclosed funding
161companies funded
372disclosed rounds
4rounds last 90 days
Most active investors
Gov12 rounds
Notable founders
Demis Hassabis
Founder & CEO · Isomorphic Labs
Mostafa ElSayed
Co-Founder & CEO · Automata
Cahal Cormican
Co-Founder · Cirdan Imaging
Stephen Dunniece
Co-Founder · Cirdan Imaging
Lee Cronin
Founder & CEO · Chemify
Jake Taylor-King
Co-Founder & Chief Innovation Officer · Relation
Charles Roberts
Co-Founder · Relation
David Holden
Co-Founder & CEO · Techspert
Murat Tunaboylu
Co-Founder & CEO · Antiverse
Ben Holland
Co-Founder & CTO · Antiverse
Graham Richards
Founder & Chairman · Oxford Drug Design
Alan Roth
CEO · Oxford Drug Design
Prism market signals · United Kingdom · country-scoped Prism corpus, 3,727,682 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · United Kingdom
How research on Biotechnology is moving in the United Kingdom
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,508 United Kingdom-affiliated papers.
research sentiment over time
200820152026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and steady — the enthusiastic (strongly-positive) share moved 44% → 43% across 2008–2026.
top research entities
- Imperial College London70
- University College London67
- University of Cambridge54
- University of Edinburgh54
- University of Oxford48
leading researchers
Pratyush Mishra · Yang Yu · Boyan Zhang · Xianzhe Jiang · Yi Cui · Yuqing Shang · Vikas Kumar · Yiu Lam
▲
Breakthroughs427 · 28%
▼ 31%→28% share
▼0.9× share momentum0 median citations79% since 2021mostly empirical
Messenger RNA and Transcription research newly emerged, while Gene topic surged 4→31, signalling intensifying genomic-decoding focus.
rising sub-themes (early→recent)
- Gene4→31
- Population1→15
- Mutation1→13
- Chromatin1→11
- Mutant2→12
Newly emergingTranscription (linguistics) 0→19 · Messenger RNA 0→15 · Genome 0→12
Landmark Biomedical photoacoustic imaging · 2,130 cites
◆
Advancements509 · 34%
▲ 24%→36% share
▲1.5× share momentum0 median citations85% since 2021mostly empirical
Advancements field-share rose 24→36% as Antimicrobial research jumped 1→22 and Metagenomics newly emerged, reflecting accelerating microbial-intervention work.
rising sub-themes (early→recent)
- Gene2→35
- Antimicrobial1→22
- Bacteria1→17
- Downregulation and upregulation1→17
- Antibody3→19
Newly emergingMicroorganism 0→14 · Fermentation 0→14 · Metagenomics 0→13
Landmark Microtiter Dish Biofilm Formation Assay · 2,147 cites
▼
Concerns322 · 21%
▼ 32%→18% share
▼0.6× share momentum0 median citations68% since 2021mostly reviews
Agriculture concerns intensified 9→18 alongside brand-new Outbreak and Malaria signals, flagging rising biosecurity and crop-risk scrutiny.
rising sub-themes (early→recent)
- Production (economics)3→14
- Antimicrobial4→14
- Agriculture9→18
- Sustainability1→10
- Food safety2→11
Newly emergingMalaria 0→7 · Risk assessment 0→6 · Outbreak 0→6
Landmark Antibiotic resistance: a rundown of a global crisis · 2,496 cites
RESEARCH HOTSPOTS · United Kingdom
Where biotechnology is researched across United Kingdom
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
London258 · +0.43
Oxford75 · +0.46
Edinburgh69 · +0.43
Cambridge61 · +0.61
Glasgow34 · +0.44
Manchester28 · +0.57
Birmingham27 · +0.51
Bristol20 · +0.42
PATENT SIGNAL · United Kingdom
Who's filing biotechnology patents in the United Kingdom
United Kingdom biotechnology patent filing is accelerating — 35,956 filings from 8,000 assignees (2016–2025), led by Medimmune, Glaxo Group, UCL Business; annual filings 2688→3463.
35,956 filings8,000 assigneespeak 4311/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
- Medimmune2939
- Glaxo Group1583
- UCL Business1576
- UNIV Oxford Innovation1145
- Glaxosmithkline IP DEV997
- Medical RES Council948
- Cambridge Entpr859
- Kymab850
Common questions
How many Life Sciences Tech companies are there in United Kingdom?
Radar tracks 418 indexable Life Sciences Tech companies headquartered in United Kingdom that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Tech companies in United Kingdom?
The Life Sciences Tech companies in United Kingdom on this list have raised a combined $5.3B in disclosed equity funding across 161 funded companies.
Which is the highest-funded Life Sciences Tech company in United Kingdom?
Isomorphic Labs is the highest-funded Life Sciences Tech company in United Kingdom, with $2.7B in disclosed equity funding.
How many Life Sciences Tech companies in United Kingdom are funded?
161 of the 418 Life Sciences Tech companies in United Kingdom on this list have disclosed at least one equity funding round.
How many Life Sciences Tech unicorns are there in United Kingdom?
None of the Life Sciences Tech companies in United Kingdom on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in United Kingdom Life Sciences Tech companies?
The most active investors in United Kingdom Life Sciences Tech companies on this list include Europa, Entrepreneur First, Cambridge Angels, Gov, Oxford University Innovation.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.